ELI
PTLA

Empire Life Investments’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Empire Life Investments’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-106,225
Closed -$757K – 109
2020
Q1 		$757K Buy
106,225
+369
+0.3% +$4.6K 0.07% 85
2019
Q4 		$2.53M Buy
105,856
+644
+0.6% +$17.8K 0.19% 65
2019
Q3 		$2.82M Buy
105,212
+46,053
+78% +$1.29M 0.24% 69
2019
Q2 		$1.6M Buy
59,159
+940
+2% +$29.5K 0.13% 76
2019
Q1 		$2.02M Sell
58,219
-78,833
-58% -$2.27M 0.17% 71
2018
Q4 		$2.67M Buy
+137,052
New +$2.82M 0.24% 71

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return

Empire Life Investments's PTLA Position: Q2 2020 in Review

Empire Life Investments sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 106,225 shares — an estimated $757K sold.

Empire Life Investments first reported a position in PTLA in Q4 2018 and held it in 6 quarters. The position peaked at $2.82M in Q3 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Empire Life Investments reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Empire Life Investments sold 106,225 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $757K.
  • Empire Life Investments first reported a position in Portola Pharmaceuticals, Inc. in Q4 2018 and held it in 6 quarters.
  • Empire Life Investments's Portola Pharmaceuticals, Inc. position peaked at $2.82M in Q3 2019.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Empire Life Investments's 13F filing for Q2 2020, filed 3 Aug 2020.